Interchangeability and Pharmacy-Level Substitution

Array

Activity Info

Upon completion of the activity, participants should be able to:
1. Summarize key aspects of current and proposed regulations regarding interchangeability and pharmacist-level substitution with biosimilars
2. Access information on approved biosimilars to determine if pharmacy-level substitution will be applicable
Email

CME/CE credit is no longer available for this activity.

Search